FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review  Endpoints NewsVanda Pharmaceuticals (VNDA) Faces FDA Setback on HETLIOZ Application  GuruFocusVanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder  PR Newswire